S&P 500 7,718.60 −0.38%
Nasdaq 26,506.99 −0.29%
S&P/TSX 36,513.80 −0.33%
Apple 319.97 −2.51%
Nvidia 230.36 +0.84%
Microsoft 499.70 −2.04%
Shopify 200.76 −0.10%
Royal Bank 291.48 −0.30%
CAD/USD 0.7230 −0.30%
CLOSED · 17:40 ET
Market ClerkRecap
Sun Sep 6 · markets closed2 signals today321 insider buys this week · $404MCIRO short report next: Sep 15The week ahead
KL
INSIDER · ORKA · Oruka Therapeutics, Inc. · CHIEF EXECUTIVE OFFICER

Klein Lawrence Otto

Every open-market transaction filed under this name, Sep 1 to Sep 1.

Filings
3
0 buys · 3 sells
Bought
open market, at cost
Sold
$6.9M
includes scheduled sales
Buys since
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Sep 1ORKAOruka Therapeutics, Inc.Chief Executive OfficerSell4,800$92.44$444K−1.6%
Sep 1ORKAOruka Therapeutics, Inc.Chief Executive OfficerSell63,596$91.90$5.8M−1.0%
Sep 1ORKAOruka Therapeutics, Inc.Chief Executive OfficerSell6,604$90.79$600K+0.2%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.